Basit öğe kaydını göster

The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN.

dc.contributor.authorGiven, Robert
dc.contributor.authorChi, Kim N.
dc.contributor.authorMerseburger, Axel S.
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorChowdhury, Simon
dc.contributor.authorBjartell, Anders
dc.contributor.authorChung, Byung
dc.contributor.authorGomes, Andrea Juliana Pereira de Santana
dc.contributor.authorJuarez, Alvaro
dc.contributor.authorUemura, Hirotsugu
dc.contributor.authorYe, Dingwei
dc.contributor.authorKarsh, Lawrence Ivan
dc.contributor.authorGartrell, Benjamin Adam
dc.contributor.authorBrookman-May, Sabine D.
dc.contributor.authorMundle, Suneel
dc.contributor.authorMcCarthy, Sharon Anne
dc.contributor.authorLefresne, Florence
dc.contributor.authorRooney, Oliver Brendan
dc.contributor.authorBhaumik, Amitabha
dc.contributor.authorAgarwal, Neeraj
dc.date.accessioned2022-07-04T12:23:39Z
dc.date.available2022-07-04T12:23:39Z
dc.date.issued2022
dc.identifier.citationChi K. N. , Merseburger A. S. , Ozguroglu M., Chowdhury S., Bjartell A., Chung B., Gomes A. J. P. d. S. , Given R., Juarez A., Uemura H., et al., "The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN.", JOURNAL OF CLINICAL ONCOLOGY, cilt.40, sa.6, 2022
dc.identifier.issn0732-183X
dc.identifier.otherav_19eb1cdb-1c71-4371-a917-9716f2bf94db
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181797
dc.identifier.urihttps://doi.org/10.1200/jco.2022.40.6_suppl.089
dc.language.isoeng
dc.subjectOncology
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectHealth Sciences
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleThe effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN.
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume40
dc.identifier.issue6
dc.contributor.firstauthorID3405560


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster